Not logged inPharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers
Wang, Xiaodong; Kirk, Rachel; Matijevic, Mark; Gao, Minggeng; Poma, Allen; Quinn, Shauna; Arora, Sujata; Fischer, Tanya .png)
Share.png)
SaveOral venglustat in Parkinson disease patients with a GBA mutation: Study design of part 2 of the MOVES-PD trial and patient characteristicsPeterschmitt, M. Judith; Gurevich, Tanya; Gasser, Thomas; Saiki, Hidemoto; Isaacson, Stuart; Waters, Cheryl; Wills, Anne-Marie; Hassin-Baer, Sharon; Simuni, Tanya; Gaemers, Sebastiaan J. M.; Sardi, S. Pablo; Saubadu, Stephane; Minini, Pascal; Fischer, Tanya Share Save Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseasesLyn, Nicole; Pulikottil-Jacob, Ruth; Rochmann, Camille; Krupnick, Robert; Gwaltney, Chad; Stephens, Nick; Kissell, Julie; Cox, Gerald F.; Fischer, Tanya; Hamed, Alaa Share Save Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 'I of the MOVES-PD studyPeterschmitt, M. Judith; Saiki, Hidemoto; Hatano, Taku; Gasser, Thomas; Isaacson, Stuart; Kulisevsky, Jaime; Simuni, Tanya; Takahashi, Yuji; Wills, Anne-Marie; Guedes, Leonor Correia; Svenningsson, Per; Takahashi, Ryosuke; Waters, Cheryl; Katsuno, Masahisa; Ji, Allena Ji; Gaemers, Sebastiaan J. M.; Minini, Pascal; Nembo, Blandine; Sardi, Pablo; Saubadu, Stephane; Sharma, Jyoti; Fischer, Tanya Share Save Share Save Venglustat combined with imiglucerase positively affects neurological features and brain connectivity in adults with Gaucher disease type 3Schiffmann, Raphael; Cox, Timothy M.; Ida, Hiroyuki; Mengel, Eugen; Mistry, Pramod; Crawford, Nigel; Gaemers, Sebastiaan; Ji, Allena; Peterschmitt, M. Judith; Sharma, Jyoti; Zhang, Qi; Fischer, Tanya Share Save Share Save Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studySimuni, Tanya; Uribe, Liz; Cho, Hyunkeun Ryan; Caspell-Garcia, Chelsea; Coffey, Christopher S.; Siderowf, Andrew; Trojanowski, John Q.; Shaw, Leslie M.; Seibyl, John; Singleton, Andrew; Toga, Arthur W.; Galasko, Doug; Foroud, Tatiana; Tosun, Duygu; Poston, Kathleen; Weintraub, Daniel; Mollenhauer, Brit; Tanner, Caroline M.; Kieburtz, Karl; Chahine, Lana M.; Reimer, Alyssa; Hutten, Samantha J.; Bressman, Susan; Marek, Kenneth; Arnedo, Vanessa; Clark, Adrienne; Fraiser, Mark; Kopil, Catherine; Chowdhury, Sohini; Sherer, Todd; Daegele, Nichole; Salerno, Christina; Casaceli, Cynthia; Dorsey, Ray; Wilson, Renee; Mahes, Sugi; Crawford, Karen; Casalin, Paola; Malferrari, Giulia; GaniWeisz, Mali; Orr-Urtreger, Avi; Montine, Thomas; Baglieri, Chris; Christini, Amanda; Russell, David; Dahodwala, Nabila; Giladi, Nir; Factor, Stewart; Hogarth, Penelope; Standaert, David; Hauser, Robert; Jankovic, Joseph; Saint-Hilaire, Marie; Richard, Irene; Shprecher, David; Fernandez, Hubert; Brockmann, Katrina; Rosenthal, Liana; Barone, Paolo; Espay, Alberto; Rowe, Dominic; Marder, Karen; Santiago, Anthony; Hu, Shu-Ching; Isaacson, Stuart; Corvol, Jean-Christophe; Ruiz Martinez, Javiar; Tolosa, Eduardo; Tai, Yen; Politis, Marios; Smejdir, Debra; Rees, Linda; Williams, Karen; Kausar, Farah; Williams, Karen; Richardson, Whitney; Willeke, Diana; Peacock, Shawnees; Sommerfeld, Barbara; Freed, Alison; Wakeman, Katrina; Blair, Courtney; Guthrie, Stephanie; Harrell, Leigh; Hunter, Christine; Thomas, Cathi-Ann; James, Raymond; Zimmerman, Grace; Brown, Victoria; Mule, Jennifer; Hilt, Ella; Ribb, Kori; Ainscough, Susan; Wethington, Misty; Ranola, Madelaine; Santana, Helen Mejia; Moreno, Juliana; Raymond, Deborah; Speketer, Krista; Carvalo, Stephanie; Croitoru, Ioana; Garrido, Alicia; Payne, Laura Marie; Viswanth, Veena; Severt, Lawrence; Facheris, Maurizio; Soares, Holly; Mintun, Mark A.; Cedarbaum, Jesse; Taylor, Peggy; Biglan, Kevin; Vandenbroucke, Emily; Sheikh, Zulfiqar Haider; Bingol, Baris; Fischer, Tanya; Sardi, Pablo; Forrat, Remi; Reith, Alastair; Egebjerg, Jan; Hillert, Gabrielle Ahlberg; Saba, Barbara; Min, Chris; Umek, Robert; Mather, Joe; De Santi, Susan; Post, Anke; Boess, Frank; Taylor, Kirsten; Grachev, Igor; Avbersek, Andreja; Muglia, Pierandrea; Merchant, Kaplana; Tauscher, Johannes Share Save Share Save Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutationPeterschmitt, M. Judith; Gasser, Thomas; Isaacson, Stuart; Kulisevsky, Jaime; Mir, Pablo; Simuni, Tanya; Wills, Anne-Marie; Guedes, Leonor Correia; Svenningsson, Per; Waters, Cheryl; Ji, Allena J.; Li, Jian; Minini, Pascal; Nembo, Blandine; Saubadu, Stephane; Sharma, Jyoti; Fischer, Tanya Share Save Venglustat in adult Gaucher disease type 3: Preliminary safety, pharmacology, and exploratory efficacy from a phase 2 trial in combination with imiglucerase (LEAP)Schiffmann, Raphael; Mengel, Eugen; Crawford, Nigel; Gaemers, Sebastiaan; Hughes, Derralynn; Jovanovic, Ana; Minini, Pascal; Sharma, Jyoti; Fischer, Tanya Share Save Functional performance in late-onset GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), longitudinal data over 3 consecutive yearsPuga, Ana C.; Hamed, Alaa; Kissell, Julie; Minini, Pascal; Pabla, Anureet K.; Kahn, Susan; Eichler, Florian; Stephen, Christopher D.; Tifft, Cynthia J.; Toro, Camilo; Johnston, Jean; Lau, Heather A.; Haxton, Elizabeth; Gray-Edwards, Heather; Fischer, Tanya Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
